Results 241 to 250 of about 280,561 (284)
Some of the next articles are maybe not open access.
INTRAVITREAL DEXAMETHASONE IMPLANTATION FOR BIRDSHOT CHORIORETINOPATHY
RETINAL Cases & Brief Reports, 2017Purpose: Birdshot chorioretinopathy is a rare form of posterior uveitis. This article reports a case series of patients with HLA-A29+ birdshot chorioretinopathy managed with intravitreal dexamethasone implants.
James, Walsh, Ashvini K, Reddy
openaire +2 more sources
Safety of 6000 intravitreal dexamethasone implants
British Journal of Ophthalmology, 2019PurposeTo evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions.MethodsRetrospective multicenter analysis of intravitreal dexamethasone implant injections (700 µg) due to various retinal conditions including central retinal venous occlusion (1861 injections), diabetic macular oedema (3104 ...
Masarwa, Dua +144 more
openaire +7 more sources
Endophthalmitis After Dexamethasone Implant
Clinical & Experimental OphthalmologyABSTRACT Background The dexamethasone intravitreal implant is used to treat sight‐threatening retinal disorders. Endophthalmitis is a serious complication of intravitreal injections and requires urgent intervention.
Maryam Eghtedari +4 more
openaire +2 more sources
Dexamethasone Intravitreal Implant (Ozurdex)
Canadian Journal of Health Technologies, 2023CADTH recommends that Ozurdex not be reimbursed by public drug plans for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic and have had an inadequate response to prior anti–vascular endothelial growth factor (VEGF) therapy. Evidence from 1 clinical trial and 2 observational studies was insufficient to demonstrate
openaire +1 more source
PERSISTENT REMNANTS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX)
Retina, 2020Purpose: To describe persistent remnants of dexamethasone intravitreal implant (DEX implant) and evaluate the risk factors for remnant persistence in patients who received a DEX implant. Methods: This retrospective observational study involved a retrospective chart review of 133 ...
Jee Taek, Kim +2 more
openaire +2 more sources
Multicomponent Implant Releasing Dexamethasone
AIP Conference Proceedings, 2008Several inflammatory conditions are usually treated with corticosteroids. There are various problems like side effects with traditional applications of steroids, e.g. topical, or systemic routes. Local drug delivery systems have been studied and developed to gain more efficient administration with fewer side effects.
L. Nikkola +8 more
openaire +1 more source
MIGRATION OF INTRAVITREAL DEXAMETHASONE IMPLANT TO ANTERIOR CHAMBER
RETINAL Cases & Brief Reports, 2013Purpose: To describe two cases of migration of intravitreally injected dexamethasone implant into the anterior chamber. Methods: Charts were reviewed of two patients who received sustained-release dexamethasone implant intravitreally for chronic intractable cystoid macular edema.
Vamsi K, Gullapalli, David A, DiLoreto
openaire +2 more sources
Late Migration of Dexamethasone Implant Into Anterior Chamber
Archives of Ophthalmology, 20121942;28(4):613-631. doi:10.1001/archopht.1942.00880100047004. 12. Karpe G. Basis of clinical electroretinography. Acta Ophthalmol (Copenh). 1945; 24(suppl):84. 13. Bjork A, Karpe G. The electroretinogram in retinitis pigmentosa. Acta Ophthalmol (Copenh). 1951;29:361-376. 14. Verhoeff FH. Microscopic observations in a case of retinitis pigmentosa.
Kevin M, Cronin +2 more
openaire +2 more sources
Management of Anterior Chamber Dislocation of a Dexamethasone Implant
Klinische Monatsblätter für Augenheilkunde, 2019Abstract Purpose To characterise the surgical removal technique of a dislocated dexamethasone implant in the anterior chamber and to gauge its success by analysing corneal transparency and subsequent visual acuity recovery in the postoperative phase.
Nguyen TL, Wolfensberger TJ
openaire +3 more sources
Repositioning and follow-up of intralenticular dexamethasone implant
Journal of Cataract and Refractive Surgery, 2013We report the case of a 54-year-old man who attended our emergency department complaining of severe floaters and decreased vision in his right eye. Seven days earlier, a dexamethasone intravitreal implant (Oxurdex) had been placed for a noninfectious posterior uveitis.
Mihnea, Munteanu, Cosmin, Rosca
openaire +2 more sources

